Phase II Study of Weekly Topotecan With Bevacizumab in Platinum Resistant Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers

This study has been completed.
Sponsor:
Collaborators:
GlaxoSmithKline
Genentech
Information provided by:
Benaroya Research Institute
ClinicalTrials.gov Identifier:
NCT00343044
First received: June 20, 2006
Last updated: May 25, 2010
Last verified: May 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given
No publications provided by Benaroya Research Institute

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):